Joint Appraisal of the Radical Prostatectomy Specimen by the Urologist and the Uropathologist: Together, We Can Do It Better

European Urology

Volumn 56, Issue 6, 2009, Pages 951-955

  Montironi, Rodolfo ^a   Cheng, Liang ^b   Lopez Beltran, Antonio ^c   Mazzucchelli, Roberta ^a   Scarpelli, Marina ^a   Kirkali, Ziya ^d   Montorsi, Francesco ^e  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^d DOKUZ EYLUL UNIVERSITY   (Turkey)

^e VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOPSY; EDITORIAL; HUMAN; HUMAN TISSUE; LABORATORY; MEDICAL SPECIALIST; MORPHOLOGY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROSTATE; PROSTATE BIOPSY; PROSTATECTOMY; SURGICAL TECHNIQUE; TISSUE SECTION; UROLOGY;

BIOPSY; HUMANS; MALE; PATHOLOGY, CLINICAL; PROSTATECTOMY; PROSTATIC DISEASES; UROLOGY;

EID: 70350565657     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2009.08.016     Document Type: Editorial

References (44)

1. Bryant R.J., and Hamdy F.C. Screening for prostate cancer: an update. Eur Urol 53 (2008) 37-44
2. Gosselaar C., Roobol M.J., Roemeling S., and Schröder F.H. The role of the digital rectal examination in subsequent screening visits in the European randomized study of screening for prostate cancer (ERSPC), Rotterdam. Eur Urol 54 (2008) 581-588
3. Postma R., Schröder F.H., van Leenders G.J.L.H., et al. Cancer detection and cancer characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC) - Section Rotterdam: a comparison of two rounds of screening. Eur Urol 52 (2007) 89-97
4. Schröder F.H., Hugosson J., Roobol M.J., et al. ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360 (2009) 1320-1328
5. Dahm P., Yeung L.L., Chang S.S., and Cookson M.S. A critical review of clinical practice guidelines for the management of clinically localized prostate cancer. J Urol 180 (2008) 451-459
6. Heidenreich A., Aus G., Bolla M., et al. EAU guidelines on prostate cancer. Eur Urol 53 (2008) 68-80
7. Karakiewicz P.I., Bhojani N., Capitanio U., et al. External validation of the updated Partin tables in a cohort of North American men. J Urol 180 (2008) 898-902
8. Roemeling S., Roobol M.J., Kattan M.W., van der Kwast T.H., Steyerberg E.W., and Schröder F.H. Nomogram use for the prediction of indolent prostate cancer: impact on screen-detected populations. Cancer 110 (2007) 2218-2221
9. Montironi R, Samaratunga H, True L. International Society of Urological Pathologists (ISUP) Consensus Conference on Handling of Radical Prostatectomy Specimens. Mod Pathol. In press.
10. Dewolf W.C. Re: are doctors examining prostates in university hospital?. Eur Urol 53 (2008) 1296-1297
11. Guillonneau B. A new deal or a continuing dialogue of the deaf?. Eur Urol 53 (2008) 5
12. Eichelberg C., Erbersdobler A., Michl U., et al. Nerve distribution along the prostatic capsule. Eur Urol 51 (2007) 105-111
13. Ganzer R., Blana A., Gaumann A., et al. Topographical anatomy of periprostatic and capsular nerves: quantification and computerised planimetry. Eur Urol 54 (2008) 353-361
14. Secin F.P., Touijer K., Mulhall J., and Guillonneau B. Anatomy and preservation of accessory pudendal arteries in laparoscopic radical prostatectomy. Eur Urol 51 (2007) 1229-1235
15. Sievert K.-D., Hennenlotter J., Laible I., et al. The periprostatic autonomic nerves-bundle or layer?. Eur Urol 54 (2008) 1109-1117
16. Stolzenburg J.-U., Schwalenberg T., Horn L.-C., Neuhaus J., Constantinides C., and Liatsikos E.N. Anatomical landmarks of radical prostatecomy. Eur Urol 51 (2007) 629-639
17. van der Poel H.G., Beetsma D.B., van Boven H., and Horenblas S. Perineal salvage prostatectomy for radiation resistant prostate cancer. Eur Urol 51 (2007) 1565-1572
18. Cohen M.S., Hanley R.S., Kurteva T., et al. Comparing the Gleason prostate biopsy and Gleason prostatectomy grading system: the Lahey Clinic Medical Center experience and an international meta-analysis. Eur Urol 54 (2008) 371-381
19. Egevad L. Recent trends in Gleason grading of prostate cancer. II. Prognosis, reproducibility and reporting. Anal Quant Cytol Histol 30 (2008) 54-60
20. Egevad L. Recent trends in Gleason grading of prostate cancer: I. Pattern interpretation. Anal Quant Cytol Histol 30 (2008) 190-198
21. Helpap B., and Egevad L. Correlation of modified Gleason grading of prostate carcinoma with age, serum prostate specific antigen and tumor extent in needle biopsy specimens. Anal Quant Cytol Histol 30 (2008) 133-138
22. Helpap B., and Egevad L. Correlation of modified Gleason grading with pT stage of prostatic carcinoma after radical prostatectomy. Anal Quant Cytol Histol 30 (2008) 1-7
23. Pfitzenmaier J., Pahernik S., Tremmel T., Haferkamp A., Buse S., and Hohenfellner M. Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression?. BJU Int 102 (2008) 1413-1418
24. Van Poppel H., Collette L., Ki{dotless}rkali{dotless} Z., et al. Quality of radical prostatectomy. A feasibility study. Eur J Cancer 37 (2001) 884-891
25. Chun F.K.-H., Suardi N., Capitanio U., et al. Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy. Eur Urol 55 (2009) 617-628
26. Galosi A.B., Montironi R., Fabiani A., Lacetera V., Gallè G., and Muzzonigro G. Cystic lesions of the prostate gland: an ultrasound classification with pathological correlation. J Urol 181 (2009) 647-657
27. Pondman K.M., Fütterer J.J., ten Haken B., et al. MR-guided biopsy of the prostate: an overview of techniques and a systematic review. Eur Urol 54 (2008) 517-527
28. Neill M.G., Chabert C.C., Merrilees D.A., and Eden C.G. The impact of training on service provision in laparoscopic radical prostatectomy. BJU Int 103 (2009) 1231-1234
29. Vickers A.J., Bianco F.J., Gonen M., et al. Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique. Eur Urol 53 (2008) 960-966
30. Wink M., Frauscher F., Cosgrove D., et al. Contrast-enhanced ultrasound and prostate cancer; a multicentre European research coordination project. Eur Urol 54 (2008) 982-993
31. Yossepowitch O., Eggener S.E., Serio A.M., et al. Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy. Eur Urol 53 (2008) 950-959
32. Ficarra V., Cavalleri S., Novara G., Aragona M., and Artibani W. Evidence from robot-assisted laparoscopic radical prostatectomy: a systematic review. Eur Urol 51 (2007) 45-56
33. Kessler T.M., Burkhard F.C., and Studer U.E. Nerve-sparing open radical retropubic prostatectomy. Eur Urol 51 (2007) 90-97
34. Krambeck A.E., DiMarco D.S., Rangel L.J., et al. Radical prostatectomy for prostatic adenocarcinoma: a matched comparison of open retropubic and robot-assisted techniques. BJU Int 103 (2009) 448-453
35. Rassweiler J., Wagner A.A., Moazin M., et al. Anatomic nerve-sparing laparoscopic radical prostatectomy: comparison of retrograde and antegrade techniques. Urology 68 (2006) 587-591
36. Zorn K.C., Gofrit O.N., Orvieto M.A., Mikhail A.A., Zagaja G.P., and Shalhav A.L. Robotic-assisted laparoscopic prostatectomy: functional and pathologic outcomes with interfascial nerve preservation. Eur Urol 51 (2007) 755-763
37. Aus G. Cryosurgery for prostate cancer. J Urol 180 (2008) 1882-1883
38. Babaian R.J., Donnelly B., Bahn D., et al. Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol 180 (2008) 1993-2004
39. Blana A., Murat F.J., Walter B., et al. First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer. Eur Urol 53 (2008) 1194-1203
40. Boris R.S., Bhandari A., Krane L.S., Eun D., Kaul S., and Peabody J.O. Salvage robotic-assisted radical prostatectomy: initial results and early report of outcomes. BJU Int 103 (2009) 952-956
41. Neal D.E. Can we accurately identify men with low risk prostate cancer?. J Urol 180 (2008) 1217-1218
42. Barocas D.A., Cowan J.E., Smith Jr. J.A., and Carroll P.R. CaPSURE Investigators. What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database. J Urol 180 (2008) 1330-1334
43. van As N.J., Norman A.R., Thomas K., et al. Predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillance. Eur Urol 54 (2008) 1297-1305
44. van den Bergh R.C.N., Roemeling S., Roobol M.J., Wolters T., Schröder F.H., and Bangma C.H. Prostate-specific antigen kinetics in clinical decision-making during active surveillance for early prostate cancer-a review. Eur Urol 54 (2008) 505-516